[PDF] Top 20 Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
Has 10000 "Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome" found on our website. Below are the top 20 most common "Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome".
Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
... peak particle size of LDL was measured by both a density gradient ultracentrifugation and a pore gradient lipoprotein system (CBS Scientific, Del Mar, CA) with commercially available ... See full document
8
Relationship between Physical Activity Level, Hepatic Steatosis Presence, Metabolic Syndrome and the Risk of Developing Type 2 Diabetes in Men
... and metabolic disease represent 63% of all deaths worldwide and are considered the major causes of morbidity and ...and metabolic risk factors, according to WHO (2011), such as smoking, increased blood ... See full document
10
Clinical, epidemiological, and laboratory analysis of patients with non alcoholic steatohepatitis
... of hepatic steatosis, being classified as mild, moderate, or ...for low density lipoprotein (p = ...0.03), metabolic syndrome (p = ...mild hepatic steatosis, ... See full document
5
Circulating miRNA in patients with non alcoholic fatty liver disease and coronary artery disease
... the hepatic manifestation of metabolic ...from steatosis (fatty liver) to steatohepatitis, fi brosis and ...of metabolic syn- drome. 16 NAFLD is strongly linked to CAD and hepatic ... See full document
7
Associations between smoking, components of metabolic syndrome and lipoprotein particle size
... Methods: We included 24,389 men and 35,078 women aged between 18 and 80 years who participated in the LifeLines Cohort Study between December 2006 and January 2012; 5,685 men and 6,989 women were current smokers. ... See full document
15
Observational study of lipid profile and LDL particle size in patients with metabolic syndrome
... in lipoprotein (a) levels; we believe that it could be explained by the small sample size (n = ...two lipoprotein (a) constituents still remain to be ...their size and ... See full document
8
Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
... high density lipoprotein cholesterol (non-HDL-C) is identifi ed as a secondary target of therapy with the target being 30 mg/dl greater than the LDL-C target (ATP III ...the metabolic syndrome ... See full document
14
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
... Indirect LDL-cholesterol was obtained from the Friede- wald equation: total cholesterol – triglycerides/5 for tri- glycerides ≤400 mg/dL and direct LDL-cholesterol for triglycerides > 400. [3] Direct LDL-cholesterol ... See full document
10
Prevalence of metabolic syndrome and the comparison of fasting plasma glucose and HbA1c as the glycemic criterion for MetS definition in non-diabetic population in Ghana
... some metabolic syndrome (MetS) components, which buttresses the influence of HbA1c in MetS ...of metabolic syndrome, increased with increasing quartile of HbA1c ... See full document
8
Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women
... Menopause, which is the permanent cessation of men- struation following loss of ovarian activity, has consider- able impact on social, reproductive, physical and psychological health of the woman. It has been shown that ... See full document
7
Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin
... HC individuals went through a four-week washout hav- ing a low fat diet according to the American Heart Asso- ciation recommendation [37]. One-hundred-forty-one individuals from HC group had indication of ... See full document
11
Periodontal pocket depth and salivary calcium and phosphorous levels among obese yemenis patients
... Obesity is an increasing of body fat formation and it is considered as a systemic condition that is according to World Health Organization (WHO) definition and it may be lead to low patients age and systemic ... See full document
5
Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
... detecting steatosis involving at least 20% of the hepatocytes ...of steatosis also in pediatric ...predicting steatosis has been identified, with ...liver steatosis with a very high ...liver ... See full document
9
Clinical utility of low-density lipoprotein particle measurement in management of cardiovascular disease: a case report
... achieved low population-equivalent LDL-P targets. By utilizing lipoprotein information, appropriate patient selection will identify those who should receive suitable medication, leading to better health ... See full document
6
The New Molecular Entity Evolocumab, One Kind of PCSK9 Inhibitor, Reduce Plasma Small Size LDL Cholesterol Levels by Using a New Standardized Method of Measuring LDL Size
... the lipoprotein densitometric patterns by 3% PAGE before (a) and after (b) the add-on therapy of 140 mg ...mid-band lipoprotein-C levels from total ...LDL, low-density lipoprotein; ... See full document
23
Comparison of body mass index and waist circumference as predictors of cardiometabolic health in a population of young Canadian adults
... body size, as measured by BMI, which is the most widely used measure of body size because of its practical value in both clinical practice and large-scale epidemiological studies to define obesity and ... See full document
8
Characteristics of Type 2 Diabetes Patients and Their Association with the Metabolic Syndrome and Cardiovascular Risk Factors at Thika Level Five Hospital in Kenya
... Moreover our current study showed different association of patient characteristics with MetS risk factors and selected CVD risk factors. (Table 7) using multiple logistic regression. Studies have shown that occupation ... See full document
14
“Study of Wattakaka Volubilis on Tissue Lipids and Antioxidants in Aluminium Sulphate Exposed Rats” by S.Usha Rani, R.Anuradha, India.
... Antioxidant enzymes were measured by Catalase(CAT) 32 , Super oxide dismutase (SOD) 33 , Lipid peroxidation (LPO) 34 , Reduced glutathione (GSH) 35 , Glutathione peroxidase (GPx) 36 and Glutathione reductase (GR) 37 ... See full document
6
Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects
... hypercholesterolemia was 53 and 59% of normal. The activity of the rate-limiting enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl coenzyme A reductase was normal; however, the total hepatic ... See full document
9
A Comparative study of Lipid Profile among Smokers and non Smokers
... Difference in mean values for cigarette and bidi smokers were not statistically significant which is similar to the observation of Rustogi et al 12 but the mean value of HDL was lower in bidi smokers than in cigarette ... See full document
6
Related subjects